Jennifer Chow

Ms. Chow joined the group in November 2020 from the leading cell therapy company, Kite where she was Vice President/Head of Global Marketing, Analytics and Commercial Operations. Prior to Kite, Ms. Chow was the Global Cell Therapy Commercial Lead at Celgene Corporation defining the global commercial strategy and operating model for Celgene cell therapies. Ms Chow has worked on 4 of the 6 FDA approved CAR T cell therapies and has over 20 years' experience in the biotech and pharmaceutical field.